Hypothyroidism as a predictive factor for good clinical outcomes in patients with advanced hepatocellular carcinoma undergoing lenvatinib therapy
Hypothyroidism as a predictive factor for good clinical outcomes in patients with advanced hepatocellular carcinoma undergoing lenvatinib therapy
复制标题
甲状腺功能减退症是接受乐伐替尼治疗的晚期肝细胞癌患者良好临床结果的预测因素
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Tatehiro Kagawa
中科院分区：
文献类型：
--
作者：
Masako Shomura;Haruka Okabe;Emi Sato;Koichi Shiraishi;Shunji Hirose;Kota Tsuruya;Yoshitaka Arase;Kazuya Anzai;Tatehiro Kagawa
